Nicolas Renault

3.8k total citations · 2 hit papers
46 papers, 2.9k citations indexed

About

Nicolas Renault is a scholar working on Molecular Biology, Pharmacology and Physiology. According to data from OpenAlex, Nicolas Renault has authored 46 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 13 papers in Pharmacology and 10 papers in Physiology. Recurrent topics in Nicolas Renault's work include Receptor Mechanisms and Signaling (13 papers), Adenosine and Purinergic Signaling (10 papers) and Pharmacological Receptor Mechanisms and Effects (9 papers). Nicolas Renault is often cited by papers focused on Receptor Mechanisms and Signaling (13 papers), Adenosine and Purinergic Signaling (10 papers) and Pharmacological Receptor Mechanisms and Effects (9 papers). Nicolas Renault collaborates with scholars based in France, Belgium and United States. Nicolas Renault's co-authors include Bruno Tassin, Rachid Dris, Vincent Rocher, Johnny Gaspéri, Philippe Chavatte, Ralf Jockers, Amaury Farce, Philippe Delagrange, Erika Cecon and Régis Millet and has published in prestigious journals such as Nucleic Acids Research, Angewandte Chemie International Edition and Nature Communications.

In The Last Decade

Nicolas Renault

46 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Microplastic contamination in an urban area: a case study in Greater Paris

2015 1.3k citations Nicolas Renault et al. profile →
Update on melatonin receptors: IUPHAR Review 20

2016 321 citations Ralf Jockers, Philippe Delagrange et al. British Journal of Pharmacology profile →

Peers

Countries citing papers authored by Nicolas Renault

Since Specialization

Citations

This map shows the geographic impact of Nicolas Renault's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicolas Renault with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicolas Renault more than expected).

Fields of papers citing papers by Nicolas Renault

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicolas Renault. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicolas Renault. The network helps show where Nicolas Renault may publish in the future.

Co-authorship network of co-authors of Nicolas Renault

This figure shows the co-authorship network connecting the top 25 collaborators of Nicolas Renault. A scholar is included among the top collaborators of Nicolas Renault based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicolas Renault. Nicolas Renault is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	LIBX‐A401: A Novel Selective Inhibitor of Acyl‐CoA Synthetase Long Chain Family Member 4 (ACSL4) and Its Binding Mode 2025 ·Angewandte Chemie International Edition ·(unknown), Séverine Ravez, Didier Vertommen, Nicolas Renault, Nicolas Papadopoulos, (unknown), (unknown), Karine Porte, (unknown), Nathalie Hennuyer, Gaëtan Herinckx, (unknown), Aurélie Jonneaux, Jean‐Christophe Devedjian, David Devos, Bart Staels, Patricia Melnyk, Stefan N. Constantinescu, Raphaël Frédérick, Jamal El Bakali	4
2	LIBX‐A401: A Novel Selective Inhibitor of Acyl‐CoA Synthetase Long Chain Family Member 4 (ACSL4) and Its Binding Mode 2025 ·Angewandte Chemie ·(unknown), Séverine Ravez, Didier Vertommen, Nicolas Renault, Nicolas Papadopoulos, (unknown), (unknown), Karine Porte, (unknown), Nathalie Hennuyer, Gaëtan Herinckx, (unknown), Aurélie Jonneaux, Jean‐Christophe Devedjian, David Devos, Bart Staels, Patricia Melnyk, Stefan N. Constantinescu, Raphaël Frédérick, Jamal El Bakali	2
3	Discovery of Potent Acyl-CoA Synthetase Long-Chain Family Member 4 (ACSL4) Inhibitors with Antiferroptotic Properties 2025 ·Journal of Medicinal Chemistry ·(unknown), (unknown), (unknown), (unknown), Nicolas Renault, Aurélie Jonneaux, (unknown), (unknown), Jean‐Christophe Devedjian, Patricia Melnyk, Saı̈d Yous, David Devos, Raphaël Frédérick, Séverine Ravez, Jamal El Bakali	1
4	Melatonin drugs inhibit SARS-CoV-2 entry into the brain and virus-induced damage of cerebral small vessels 2022 ·Cellular and Molecular Life Sciences ·Erika Cecon, Daniela Fernandois, Nicolas Renault, Caio Fernando Ferreira Coêlho, Jan Wenzel, (unknown), (unknown), Sarah Gallet, Sophie Le Poder, Bernard Klonjkowski, Markus Schwaninger, Vincent Prévot, Julie Dam, Ralf Jockers	24
5	Pyrazolones as inhibitors of immune checkpoint blocking the PD-1/PD-L1 interaction 2022 ·European Journal of Medicinal Chemistry ·(unknown), Romain Magnez, Frédérique Klupsch, Natascha Leleu‐Chavain, (unknown), Morgane Tardy, (unknown), Xavier Dezitter, Nicolas Renault, Gérard Vergoten, Christian Bailly, Bruno Quesnel, Xavier Thuru, Régis Millet	19
6	A phenotypic approach to the discovery of compounds that promote non-amyloidogenic processing of the amyloid precursor protein: Toward a new profile of indirect β-secretase inhibitors 2018 ·European Journal of Medicinal Chemistry ·(unknown), (unknown), (unknown), Pascal Carato, Nicolas Renault, (unknown), Sabiha Eddarkaoui, Catherine Baud, (unknown), Luc Buée, Jamal El Bakali, Valérie Vingtdeux, Nicolas Sergeant, Patricia Melnyk	8
7	New phenylaniline derivatives as modulators of amyloid protein precursor metabolism 2018 ·Bioorganic & Medicinal Chemistry ·(unknown), (unknown), (unknown), Nicolas Renault, (unknown), (unknown), Saı̈d Yous, Luc Buée, Nicolas Sergeant, (unknown)	7
8	Synthesis of triazoloquinazolinone based compounds as tubulin polymerization inhibitors and vascular disrupting agents 2016 ·European Journal of Medicinal Chemistry ·Mohsine Driowya, Julien Leclercq, (unknown), (unknown), Marie Lecoeur, Nicolas Renault, Nathalie Flouquet, Alina Ghinet, Pascal Berthelot, Nicolas Lebègue	31
9	Relationships between Th1 or Th2 iNKT Cell Activity and Structures of CD1d-Antigen Complexes: Meta-analysis of CD1d-Glycolipids Dynamics Simulations 2014 ·PLoS Computational Biology ·(unknown), Nicolas Renault, Amaury Farce, Philippe Chavatte, Éric Hénon	5
10	Virtual Screening of CB₂ Receptor Agonists from Bayesian Network and High‐Throughput Docking: Structural Insights into Agonist‐Modulated GPCR Features 2012 ·Chemical Biology & Drug Design ·Nicolas Renault, (unknown), Amaury Farce, Jamal El Bakali, Roxane Mansouri, Philippe Gervois, Régis Millet, Pierre Desreumaux, Christophe Furman, Philippe Chavatte	19
11	New FAAH inhibitors based on 3-carboxamido-5-aryl-isoxazole scaffold that protect against experimental colitis 2011 ·Bioorganic & Medicinal Chemistry ·(unknown), Giulio G. Muccioli, Mathilde Body–Malapel, Jamal El Bakali, Madjid Djouina, Nicolas Renault, Philippe Chavatte, Pierre Desreumaux, Didier Lambert, Régis Millet	38
12	Genetic polymorphism of CYP4A11 and CYP4A22 genes and in silico insights from comparative 3D modelling in a French population 2011 ·Gene ·Christian L. Lino Cardenas, Nicolas Renault, Amaury Farce, Christelle Cauffiez, Delphine Allorge, Jean‐Marc Lo‐Guidice, Michel Lhermitte, Philippe Chavatte, Franck Broly, Dany Chevalier	13
13	Novel structural insights for drug design of selective 5-HT2C inverse agonists from a ligand-biased receptor model 2010 ·European Journal of Medicinal Chemistry ·Nicolas Renault, Arnaud Gohier, Philippe Chavatte, Amaury Farce	5
14	The end of a myth: cloning and characterization of the ovine melatonin MT₂ receptor 2009 ·British Journal of Pharmacology ·Francis Cogé, (unknown), (unknown), Martine Migaud, (unknown), (unknown), Céline Legros, Christine Ouvry, William Cohen, Nicolas Renault, Olivier Nosjean, B. Malpaux, Philippe Delagrange, Jean A. Boutin	56
15	Structural Insight into PPARγ Ligands Binding 2009 ·Current Medicinal Chemistry ·Amaury Farce, Nicolas Renault, Philippe Chavatte	42
16	Mutations in components of complement influence the outcome of Factor I-associated atypical hemolytic uremic syndrome 2009 ·Kidney International ·Frank Bienaimé, Marie‐Agnès Dragon‐Durey, Catherine H. Régnier, Sara C. Nilsson, W. H. Kwan, Jacques Blouin, Mathieu Jablonski, Nicolas Renault, Marie‐Anne Rameix‐Welti, Chantal Loirat, Catherine Sautès‐Fridman, Bruno O. Villoutreix, Anna M. Blom, Véronique Frémeaux‐Bacchi	140
17	Characterisation of novel defective thiopurine S-methyltransferase allelic variants 2008 ·Biochemical Pharmacology ·Anne Garat, Christelle Cauffiez, Nicolas Renault, Jean‐Marc Lo‐Guidice, Delphine Allorge, (unknown), Nicole Houdret, Philippe Chavatte, Marie‐Anne Loriot, Jean‐Luc Gala, Franck Broly	42
18	Homology modeling of MT1 and MT2 receptors 2008 ·European Journal of Medicinal Chemistry ·Amaury Farce, Anton O. Chugunov, Cédric Logé, (unknown), Saı̈d Yous, Sébastien Dilly, Nicolas Renault, Gérard Vergoten, Roman G. Efremov, Daniel Lesieur	23
19	Free Resources to Assist Structure-Based Virtual Ligand Screening Experiments 2007 ·Current Protein and Peptide Science ·Bruno O. Villoutreix, Nicolas Renault, David Lagorce, Matthieu Montès, Maria A. Miteva	72
20	RPBS: a web resource for structural bioinformatics 2005 ·Nucleic Acids Research ·(unknown), François Moreews, (unknown), Mathieu Carpentier, (unknown), (unknown), Nicolas Renault, (unknown), Hubert Cantalloube, Jacques Chomilier, Joëlle Hochez, Joël Pothier, Bruno O. Villoutreix, J.F. Zagury, Pierre Tufféry	78

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact